SYNTHESE VON AMMONIUMDINITRAMID (ADN)

European patent · EP3853174 · In force

Register entry

Publication number
EP3853174
Application number
EP18779820
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 17, 2018
Published
Jul 28, 2021
Granted
Nov 9, 2022
Protection ends at the latest
Sep 16, 2038
Next annual fee due
Sep 30, 2027
IPC classes
C01B 21/087 (2006.01)
C01C 1/14 (2006.01)
C07C 279/00 (2006.01)
C06B 31/00 (2006.01)
C07C 277/08 (2006.01)
PCT application
PCT/SE2018/050939 17.09.2018
PCT publication
WO2020/060451 26.03.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  4. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

  5. Sep 20, 2023

    Change

    Published in Swissreg on 20.09.2023

  6. Jan 10, 2023

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 10.01.2023

  7. Nov 9, 2022

    Granted

    Published in Swissreg on 09.11.2022

Parties

Holder

TOTALFÖRSVARETS FORSKNINGSINSTITUT

Totalförsvarets Forskningsinstitut

164 90 Stockholm, SE

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

EK, Stefan

14725 Tumba, SE

JOHANSSON, Jonas

14725 Tumba, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.